Plasma tau in Alzheimer disease

OBJECTIVE: To test whether plasma tau is altered in Alzheimer disease (AD) and whether it is related to changes in cognition, CSF biomarkers of AD pathology (including β-amyloid [Aβ] and tau), brain atrophy, and brain metabolism. METHODS: This was a study of plasma tau in prospectively followed pati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurology
Hlavní autoři: Mattsson, Niklas, Zetterberg, Henrik, Janelidze, Shorena, Insel, Philip S., Andreasson, Ulf, Stomrud, Erik, Palmqvist, Sebastian, Baker, David, Tan Hehir, Cristina A., Jeromin, Andreas, Hanlon, David, Song, Linan, Shaw, Leslie M., Trojanowski, John Q., Weiner, Michael W., Hansson, Oskar, Blennow, Kaj
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089525/
https://ncbi.nlm.nih.gov/pubmed/27694257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003246
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky